Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.
A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess ...
Dr. Khashayar Rafatzand is an Iranian-Canadian doctor in Montreal, who is changing the narrative when it comes to diagnosing ...
Discover Magazine on MSN
How Common Really Is Prostate Cancer and How Easy Is it to Get Tested?
Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.
By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...
Clarity Pharmaceuticals (ASX: CU6) (Clarity or Company), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients ...
THE march of AI now seems unstoppable in every part of our lives, from choosing the TV we watch to making our trains run on ...
As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...
Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...
This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...
The 'Today' anchor was diagnosed in 2020, and after being declared cancer-free, he remains passionate about increasing awareness of the disease, especially for Black men Five years ago, Al Roker had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback